Membrane estrogen receptor α signaling modulates the sensitivity to estradiol treatment in a dose- and tissue- dependent manner
Authors:
Open Access
- 3 June 2023
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-9
Abstract
Estradiol (E2) affects both reproductive and non-reproductive tissues, and the sensitivity to different doses of E2 varies between tissues. Membrane estrogen receptor α (mERα)-initiated signaling plays a tissue-specific role in mediating E2 effects, however, it is unclear if mERα signaling modulates E2 sensitivity. To determine this, we treated ovariectomized C451A females, lacking mERα signaling, and wildtype (WT) littermates with physiological (0.05 μg/mouse/day (low); 0.6 μg/mouse/day (medium)) or supraphysiological (6 μg/mouse/day (high)) doses of E2 (17β-estradiol-3-benzoate) for three weeks. Low-dose treatment increased uterus weight in WT, but not C451A mice, while non-reproductive tissues (gonadal fat, thymus, trabecular and cortical bone) were unaffected in both genotypes. Medium-dose treatment increased uterus weight and bone mass and decreased thymus and gonadal fat weights in WT mice. Uterus weight was also increased in C451A mice, but the response was significantly attenuated (− 85%) compared to WT mice, and no effects were triggered in non-reproductive tissues. High-dose treatment effects in thymus and trabecular bone were significantly blunted (− 34% and − 64%, respectively) in C451A compared to WT mice, and responses in cortical bone and gonadal fat were similar between genotypes. Interestingly, the high dose effect in uterus was enhanced (+ 26%) in C451A compared to WT mice. In conclusion, loss of mERα signaling reduces the sensitivity to physiological E2 treatment in both non-reproductive tissues and uterus. Furthermore, the E2 effect after high-dose treatment in uterus is enhanced in the absence of mERα, suggesting a protective effect of mERα signaling in this tissue against supraphysiological E2 levels.Keywords
Funding Information
- Knut and Alice Wallenberg Foundation (2015-0317)
- Swedish Research Council (2017-01286)
- ALF-agreement (ALFGBG721581)
- Gustaf V 80-years fund (FAI-2018-0466)
- IngaBritt and Arne Lundberg Foundation (LU2017-0076)
- Ragnar Söderberg’s Foundation (M133/12)
- Novo Nordisk Foundation (26844)
- University of Gothenburg
This publication has 41 references indexed in Scilit:
- Estrogen receptor-α signaling in osteoblast progenitors stimulates cortical bone accrualJournal of Clinical Investigation, 2012
- Tissue-Specific Effects of Loss of Estrogen during Menopause and AgingFrontiers in Endocrinology, 2012
- Activation function 2 (AF2) of estrogen receptor-α is required for the atheroprotective action of estradiol but not to accelerate endothelial healingProceedings of the National Academy of Sciences, 2011
- Roles of transactivating functions 1 and 2 of estrogen receptor-α in boneProceedings of the National Academy of Sciences, 2011
- PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantificationNucleic Acids Research, 2009
- New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formationBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2009
- Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal womenFertility and Sterility, 2009
- Investigation of central versus peripheral effects of estradiol in ovariectomized miceJournal of Endocrinology, 2005
- Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.Journal of Clinical Investigation, 1994
- Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cellsNature, 1977